Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSEAMERICAN:ASXCNASDAQ:DCTHNASDAQ:NPCENASDAQ:TCMD On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeASXCAsensus Surgical$0.35$0.00$0.17▼$0.40$94.74M1.372.03 million shsN/ADCTHDelcath Systems$11.63+0.7%$13.21$4.26▼$16.97$388.83M0.85354,774 shs315,097 shsNPCENeuroPace$10.79+3.5%$11.94$5.45▼$15.11$351.32M2.03129,912 shs173,059 shsTCMDTactile Systems Technology$13.33-0.1%$14.16$11.12▼$21.10$315.94M1.21250,759 shs123,172 shs20 Stocks to Sell NowGet This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceASXCAsensus Surgical0.00%0.00%0.00%+3.67%+65.43%DCTHDelcath Systems+0.69%+10.45%-13.47%-18.73%+159.89%NPCENeuroPace+3.45%+1.41%-5.35%-9.86%-21.53%TCMDTactile Systems Technology-0.15%-0.52%-2.42%-23.39%-5.86%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationASXCAsensus Surgical0.0786 of 5 stars1.00.00.00.00.00.00.6DCTHDelcath Systems2.9672 of 5 stars3.53.00.00.03.42.50.6NPCENeuroPace2.8494 of 5 stars3.43.00.00.01.54.20.6TCMDTactile Systems Technology3.2442 of 5 stars3.01.00.00.03.12.53.1Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceASXCAsensus Surgical 2.00Hold$0.350.60% UpsideDCTHDelcath Systems 3.00Buy$22.7595.61% UpsideNPCENeuroPace 2.80Moderate Buy$15.2040.87% UpsideTCMDTactile Systems Technology 2.00Hold$18.0035.03% UpsideCurrent Analyst Ratings BreakdownLatest ASXC, NPCE, DCTH, and TCMD Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/7/2025DCTHDelcath SystemsHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$22.00 ➝ $24.003/5/2025NPCENeuroPaceCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$19.00 ➝ $20.002/19/2025TCMDTactile Systems TechnologyB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Neutral$23.00 ➝ $18.001/30/2025NPCENeuroPaceWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$13.00 ➝ $17.001/21/2025NPCENeuroPaceUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$17.00(Data available from 4/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookASXCAsensus Surgical$8.58M11.04N/AN/A$0.13 per share2.68DCTHDelcath Systems$37.21M10.45N/AN/A$0.72 per share16.15NPCENeuroPace$79.91M4.40N/AN/A$0.79 per share13.66TCMDTactile Systems Technology$292.98M1.08$0.94 per share14.21$9.18 per share1.45Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateASXCAsensus Surgical-$78.43M-$0.31N/AN/AN/A-902.25%-184.10%-114.75%N/ADCTHDelcath Systems-$47.68M-$0.98N/AN/AN/A-150.70%-338.16%-104.02%5/13/2025 (Estimated)NPCENeuroPace-$32.96M-$0.95N/AN/AN/A-36.74%-205.41%-28.29%5/6/2025 (Estimated)TCMDTactile Systems Technology$28.51M$0.7019.0415.87N/A5.79%9.37%6.75%5/5/2025 (Estimated)Latest ASXC, NPCE, DCTH, and TCMD EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025NPCENeuroPace-$0.26N/AN/AN/A$21.85 millionN/A5/13/2025Q1 2025DCTHDelcath Systems$0.10N/AN/AN/A$16.83 millionN/A5/5/2025Q1 2025TCMDTactile Systems Technology-$0.07N/AN/AN/A$63.48 millionN/A3/6/2025Q4 2024DCTHDelcath Systems-$0.10-$0.11-$0.01-$0.11$14.96 million$15.10 million3/4/2025Q4 2024NPCENeuroPace-$0.25-$0.18+$0.07-$0.18$21.14 million$21.47 million2/18/2025Q4 2024TCMDTactile Systems Technology$0.31$0.40+$0.09$0.40$85.39 million$85.59 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthASXCAsensus SurgicalN/AN/AN/AN/AN/ADCTHDelcath SystemsN/AN/AN/AN/AN/ANPCENeuroPaceN/AN/AN/AN/AN/ATCMDTactile Systems TechnologyN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioASXCAsensus SurgicalN/A1.000.69DCTHDelcath SystemsN/A1.341.03NPCENeuroPace6.035.594.77TCMDTactile Systems Technology0.114.363.80Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipASXCAsensus Surgical9.35%DCTHDelcath Systems61.12%NPCENeuroPace78.83%TCMDTactile Systems Technology83.43%Insider OwnershipCompanyInsider OwnershipASXCAsensus Surgical2.87%DCTHDelcath Systems17.94%NPCENeuroPace22.20%TCMDTactile Systems Technology2.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableASXCAsensus Surgical170272.33 million264.52 millionNot OptionableDCTHDelcath Systems6033.43 million26.24 millionOptionableNPCENeuroPace17032.56 million23.22 millionOptionableTCMDTactile Systems Technology98023.67 million23.36 millionOptionableASXC, NPCE, DCTH, and TCMD HeadlinesRecent News About These CompaniesTactile Systems Technology, Inc. (NASDAQ:TCMD) Shares Sold by Kennedy Capital Management LLCApril 15 at 6:02 AM | marketbeat.com147,900 Shares in Tactile Systems Technology, Inc. (NASDAQ:TCMD) Purchased by Norges BankApril 14, 2025 | marketbeat.comTactile Systems Technology, Inc. (NASDAQ:TCMD) Shares Purchased by Arrowstreet Capital Limited PartnershipApril 14, 2025 | marketbeat.comResona Asset Management Co. Ltd. Invests $476,000 in Tactile Systems Technology, Inc. (NASDAQ:TCMD)April 13, 2025 | marketbeat.comPrudential Financial Inc. Sells 66,300 Shares of Tactile Systems Technology, Inc. (NASDAQ:TCMD)April 12, 2025 | marketbeat.comRaymond James Financial Inc. Invests $330,000 in Tactile Systems Technology, Inc. (NASDAQ:TCMD)April 12, 2025 | marketbeat.comTactile Systems Technology: Interesting Devices Company, Need More ClarityApril 7, 2025 | seekingalpha.comIntegrated Quantitative Investments LLC Purchases Shares of 64,125 Tactile Systems Technology, Inc. (NASDAQ:TCMD)April 6, 2025 | marketbeat.comTactile Systems Technology (NASDAQ:TCMD) Downgraded by StockNews.com to "Buy"March 30, 2025 | marketbeat.comEntryPoint Capital LLC Buys Shares of 19,485 Tactile Systems Technology, Inc. (NASDAQ:TCMD)March 28, 2025 | marketbeat.comSemanteon Capital Management LP Buys New Holdings in Tactile Systems Technology, Inc. (NASDAQ:TCMD)March 23, 2025 | marketbeat.comTactile Systems Technology (NASDAQ:TCMD) Rating Increased to Strong-Buy at StockNews.comMarch 22, 2025 | marketbeat.comShort Interest in Tactile Systems Technology, Inc. (NASDAQ:TCMD) Decreases By 16.5%March 19, 2025 | marketbeat.comRoyce & Associates LP Sells 65,917 Shares of Tactile Systems Technology, Inc. (NASDAQ:TCMD)March 19, 2025 | marketbeat.comThe Returns At Tactile Systems Technology (NASDAQ:TCMD) Aren't GrowingMarch 18, 2025 | finance.yahoo.comTactile Medical to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services ConferenceMarch 5, 2025 | globenewswire.comA Closer Look At Tactile Systems Technology's EarningsFebruary 26, 2025 | finance.yahoo.comElaine M. Birkemeyer Sells 3,778 Shares of Tactile Systems Technology, Inc. (NASDAQ:TCMD) StockFebruary 25, 2025 | insidertrades.comAnalysts Offer Insights on Healthcare Companies: Tactile Systems Technology (TCMD) and Cross Country Healthcare (CCRN)February 24, 2025 | markets.businessinsider.comRSI Alert: Tactile Systems Technology (TCMD) Now OversoldFebruary 24, 2025 | nasdaq.comB. Riley Securities Downgrades Tactile Systems Technology (TCMD)February 19, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeASXC, NPCE, DCTH, and TCMD Company DescriptionsAsensus Surgical NYSEAMERICAN:ASXC$0.35 0.00 (0.00%) As of 08/22/2024Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, the Middle East, Africa, and Asia. It digitizes the interface between the surgeon and the patient to perform performance-guided surgery for surgeons to deliver outcomes to patients. The company's products include Senhance System, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures; instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. is headquartered in Durham, North Carolina.Delcath Systems NASDAQ:DCTH$11.63 +0.08 (+0.69%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$11.62 -0.01 (-0.09%) As of 04/17/2025 04:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.NeuroPace NASDAQ:NPCE$10.79 +0.36 (+3.45%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$10.79 0.00 (0.00%) As of 04/17/2025 05:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.Tactile Systems Technology NASDAQ:TCMD$13.33 -0.02 (-0.15%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$13.32 -0.01 (-0.04%) As of 04/17/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Archer Aviation Unveils NYC Network Ahead of Key Earnings Report Joby Aviation Stock Presents an Opportunity in the Turbulence Tariff Exemptions Set the Stage for a Taiwan Semiconductor Rally Tariff-Resistant Kinder Morgan Is a Good Buy in 2025 Rocket Lab's Growth Potential Gains Altitude on Defense News Broadcom’s Apple Relationship: AI Opportunity Meets Tariff Risk Tariff-Resistant Abbott Laboratories on Track for New Highs Goldman Sachs Just Revealed What’s Next for Markets Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
